CLINICAL_TRIALS
trial_result
· 2012-10-05
Clinical Trial Update: Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy [Phase 3]
Summary
Phase 3 trial update reporting safety data for BEMA Fentanyl used to treat breakthrough pain in cancer patients on chronic opioid therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioDelivery Sciences International | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-10-05